Kobo Biotech Ltd

Kobo Biotech Ltd

₹ 3.80 -5.00%
28 Mar - close price
About

Kobo Biotech is engaged in the business of Pharmaceutical products.

  • Market Cap 9.05 Cr.
  • Current Price 3.80
  • High / Low 6.01 / 1.86
  • Stock P/E
  • Book Value -54.7
  • Dividend Yield 0.00 %
  • ROCE -36.8 %
  • ROE %
  • Face Value 10.0

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.72 0.80 0.27 0.70 0.30 9.24 0.34 0.21 0.17 0.79 0.23 0.20 0.20
Operating Profit -0.72 -0.80 -0.27 -0.70 -0.30 -9.24 -0.34 -0.21 -0.17 -0.79 -0.23 -0.20 -0.20
OPM %
0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00
Interest 3.60 0.00 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 1.42 1.39 1.35 1.03 1.04 1.18 1.15 0.89 1.03 1.00 1.01 1.02 1.03
Profit before tax -5.74 -2.19 -1.60 -1.86 -1.34 -10.42 -1.47 -1.10 -1.20 -1.79 -1.22 -1.22 -1.23
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-5.74 -2.19 -1.60 -1.86 -1.35 -10.42 -1.47 -1.10 -1.19 -1.79 -1.23 -1.22 -1.23
EPS in Rs -2.41 -0.92 -0.67 -0.78 -0.57 -4.37 -0.62 -0.46 -0.50 -0.75 -0.52 -0.51 -0.52
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
167.03 170.15 56.89 29.05 32.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
125.51 134.40 61.34 38.51 27.74 4.05 3.02 1.72 0.69 2.79 10.51 1.50 1.42
Operating Profit 41.52 35.75 -4.45 -9.46 4.80 -4.05 -3.02 -1.72 -0.69 -2.79 -10.51 -1.50 -1.42
OPM % 24.86% 21.01% -7.82% -32.56% 14.75%
0.23 0.22 0.18 2.60 0.42 6.00 0.04 -2.15 0.03 0.04 0.02 0.02 0.02
Interest 19.54 17.21 18.14 15.62 14.37 14.41 14.50 14.44 14.47 10.84 0.13 0.00 0.00
Depreciation 10.86 9.97 9.62 7.78 7.31 6.78 6.44 6.15 5.88 5.64 4.61 4.07 4.06
Profit before tax 11.35 8.79 -32.03 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -5.46
Tax % 11.37% 5.92% -1.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
10.07 8.27 -32.57 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -5.47
EPS in Rs 4.48 3.68 -14.48 -13.45 -6.94 -8.08 -10.04 -10.27 -8.82 -8.07 -6.39 -2.33 -2.30
Dividend Payout % 22.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 12%
3 Years: 20%
TTM: 61%
Stock Price CAGR
10 Years: -9%
5 Years: -4%
3 Years: -20%
1 Year: 95%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 22.50 22.50 22.50 22.50 23.73 23.83 23.83 23.83 23.83 23.83 23.83 23.83 23.83
Reserves 46.37 54.64 22.07 -8.83 -17.30 -42.41 -66.33 -90.79 -111.80 -131.03 -146.25 -151.81 -154.25
117.99 131.49 136.99 142.42 152.68 207.60 221.96 236.36 250.76 260.53 140.71 139.84 139.69
70.63 69.01 97.45 95.74 101.36 63.20 66.48 70.04 73.54 77.26 60.89 63.47 64.07
Total Liabilities 257.49 277.64 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 73.34
100.17 107.77 103.52 95.10 87.79 81.01 74.56 68.42 62.54 56.91 41.66 37.59 35.56
CWIP 13.49 2.92 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 0.00 0.00 0.00
Investments 10.76 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 0.00 0.00 0.00
133.07 154.76 161.05 142.29 158.24 156.77 156.94 156.58 159.35 159.24 37.52 37.74 37.78
Total Assets 257.49 277.64 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 73.34

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
57.55 38.42 11.02 19.32 5.62 32.30 31.47 20.95 14.48 2.51 93.76 0.87
-25.19 -8.42 -4.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.09 0.00
-26.98 -35.76 -7.00 -20.50 -5.27 -32.76 -31.47 -20.95 -14.47 -1.08 -120.28 -0.87
Net Cash Flow 5.38 -5.76 -0.69 -1.18 0.35 -0.46 0.00 0.00 0.00 1.43 -1.43 0.00

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 143.15 156.49 419.02 705.62 1,006.50
Inventory Days 176.24 207.82 585.06 896.42 1,038.63
Days Payable 134.95 96.88 404.72 659.54 1,092.57
Cash Conversion Cycle 184.44 267.42 599.37 942.51 952.56
Working Capital Days 151.37 197.93 571.21 829.89 821.19
ROCE % 15.48% 13.15% -7.12% -10.18% -1.33% -2.77% -5.11% -4.49% -3.94% -5.31% -17.60% -36.82%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95%
0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66%
54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.40% 54.39% 54.39% 54.37%
No. of Shareholders 5,6325,6115,6455,8626,0646,0646,2046,2046,4966,4586,4786,530

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents